Voya Investment Management LLC Sells 1,034 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Voya Investment Management LLC lessened its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 4.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,098 shares of the company’s stock after selling 1,034 shares during the period. Voya Investment Management LLC owned 0.05% of Phibro Animal Health worth $464,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Hussman Strategic Advisors Inc. bought a new stake in shares of Phibro Animal Health during the fourth quarter worth $2,205,000. Alliancebernstein L.P. raised its holdings in Phibro Animal Health by 357.1% during the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock worth $2,730,000 after purchasing an additional 101,560 shares during the last quarter. Prudential Financial Inc. lifted its position in Phibro Animal Health by 405.8% during the 4th quarter. Prudential Financial Inc. now owns 120,655 shares of the company’s stock valued at $2,534,000 after purchasing an additional 96,800 shares during the period. American Century Companies Inc. boosted its stake in shares of Phibro Animal Health by 18.0% in the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock valued at $13,348,000 after purchasing an additional 96,787 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new stake in shares of Phibro Animal Health during the 4th quarter worth approximately $2,020,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on PAHC shares. Barclays increased their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Morgan Stanley increased their price target on Phibro Animal Health from $20.00 to $21.00 and gave the company an “equal weight” rating in a research note on Thursday. Finally, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $20.00.

Phibro Animal Health Trading Up 1.0 %

Shares of NASDAQ PAHC opened at $22.48 on Friday. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The company’s fifty day moving average is $19.99 and its 200-day moving average is $21.86. The stock has a market cap of $910.51 million, a price-to-earnings ratio of 46.83, a P/E/G ratio of 0.45 and a beta of 0.62.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The firm had revenue of $347.80 million during the quarter, compared to analysts’ expectations of $352.41 million. Equities research analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.14%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.